导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 13.10% | 230/330 |
| 近一周 | -4.62% | 327/359 |
| 近一月 | -0.86% | 107/359 |
| 近一季 | 0.62% | 128/354 |
| 近半年 | 10.51% | 108/345 |
| 近一年 | 8.13% | 246/330 |
| 近两年 | 42.32% | 90/274 |
| 近三年 | 111.06% | 20/194 |
| 成立以来 | 770.12% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-8.82% 299/341 |
16.65% 48/349 |
7.67% 199/355 |
- - |
| 2024 | 24.57% 49/330 |
8.16% 68/280 |
8.06% 57/310 |
0.04% 248/319 |
6.54% 40/330 |
| 2023 | 54.14% 11/276 |
18.46% 24/205 |
20.26% 16/230 |
-3.67% 87/262 |
12.32% 52/276 |
| 2022 | -28.23% 136/202 |
-8.84% 69/153 |
-19.76% 141/164 |
0.23% 36/189 |
-2.10% 170/202 |
| 2021 | 24.56% 25/151 |
2.23% 127/312 |
9.67% 65/328 |
1.52% 33/358 |
9.43% 31/151 |
| 2020 | 34.37% 19/104 |
-10.94% 134/280 |
29.56% 39/295 |
7.98% 67/299 |
7.85% 160/305 |
| 2019 | 39.87% 4/89 |
14.41% 54/258 |
6.23% 15/268 |
3.75% 45/253 |
10.92% 51/266 |
| 2018 | 3.84% 7/80 |
- - |
- - |
- - |
-17.63% 199/241 |
| 2017 | 23.02% 23/69 |
- - |
- - |
- - |
- - |
| 2016 | 10.89% 16/59 |
- - |
- - |
- - |
- - |
| 2015 | 17.19% 1/49 |
- - |
- - |
- - |
- - |
| 2014 | 16.13% 11/99 |
- - |
- - |
- - |
- - |
| 2013 | 29.53% 4/70 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇C | 0.2364 | 27.00% |
| 嘉实标普生物科技精选行业ETF(QDII) | 1.2510 | 22.82% |
| 易方达标普生物科技美元汇A | 0.2397 | 22.61% |
| 易方达标普生物科技人民币A | 1.6917 | 21.74% |
| 易方达标普生物科技人民币C | 1.6684 | 21.66% |
| 广发生物科技指数人民币(QDII)A | 1.4510 | 17.07% |
| 广发生物科技指数美元(QDII)A | 0.2056 | 14.99% |
| 广发生物科技指数美元(QDII)C | 0.2022 | 14.89% |
| 汇添富纳斯达克生物科技ETF(QDII) | 1.4395 | 14.73% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现钞 | 1.3258 | 14.23% |
| 广发纳斯达克100ETF联接人民币(QDII)A VS. 天弘恒生科技指数(QDII)C(012349) |